{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-039023","form_type":"8-K","ticker":"COCP","cik":"0001412486","company_name":"Cocrystal Pharma, Inc.","filed_at":"2026-08-18T20:30:32+00:00","discovered_at":"2026-08-18T20:32:12.595375+00:00","generated_at":"2026-08-18T20:32:21.154979+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Cocrystal Pharma appoints Carol L. Brosgart to board of directors","bullets":["Carol L. Brosgart appointed as director effective August 12, 2026.","No arrangements or understandings with other persons regarding her selection.","No family relationships or related party transactions requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-039023","json":"https://secwatch.observer/filing/0001493152-26-039023.json","markdown":"https://secwatch.observer/filing/0001493152-26-039023.md","text":"https://secwatch.observer/filing/0001493152-26-039023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226039023/0001493152-26-039023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226039023/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T20:32:21.154979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}